FR2987831A1 - Particules d'oxyde a base de terres rares et utilisation notamment en imagerie - Google Patents

Particules d'oxyde a base de terres rares et utilisation notamment en imagerie Download PDF

Info

Publication number
FR2987831A1
FR2987831A1 FR1252167A FR1252167A FR2987831A1 FR 2987831 A1 FR2987831 A1 FR 2987831A1 FR 1252167 A FR1252167 A FR 1252167A FR 1252167 A FR1252167 A FR 1252167A FR 2987831 A1 FR2987831 A1 FR 2987831A1
Authority
FR
France
Prior art keywords
particle
particles
imaging
formula
xalb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR1252167A
Other languages
English (en)
French (fr)
Inventor
Markus Schoeffel
Antigoni Alexandrou
Cedric Bouzigues
Thierry Gacoin
Jean-Pierre Boilot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ECOLE POLYTECH
Ecole Polytechnique
Original Assignee
ECOLE POLYTECH
Ecole Polytechnique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ECOLE POLYTECH, Ecole Polytechnique filed Critical ECOLE POLYTECH
Priority to FR1252167A priority Critical patent/FR2987831A1/fr
Priority to PCT/FR2013/050500 priority patent/WO2013132197A1/fr
Priority to JP2014560435A priority patent/JP6318096B2/ja
Priority to EP13715291.4A priority patent/EP2823016A1/fr
Priority to US14/383,859 priority patent/US20150010476A1/en
Priority to CN201380023918.1A priority patent/CN104302731B/zh
Publication of FR2987831A1 publication Critical patent/FR2987831A1/fr
Priority to US15/877,042 priority patent/US20180161461A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
    • C09K11/08—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials
    • C09K11/77—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials containing rare earth metals
    • C09K11/7783—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials containing rare earth metals containing two or more rare earth metals one of which being europium
    • C09K11/7794—Vanadates; Chromates; Molybdates; Tungstates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FR1252167A 2012-03-09 2012-03-09 Particules d'oxyde a base de terres rares et utilisation notamment en imagerie Withdrawn FR2987831A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1252167A FR2987831A1 (fr) 2012-03-09 2012-03-09 Particules d'oxyde a base de terres rares et utilisation notamment en imagerie
PCT/FR2013/050500 WO2013132197A1 (fr) 2012-03-09 2013-03-08 Particules d'oxyde à base de terres rares et utilisation notamment en imagerie
JP2014560435A JP6318096B2 (ja) 2012-03-09 2013-03-08 希土類酸化物粒子及び特に画像化におけるその使用
EP13715291.4A EP2823016A1 (fr) 2012-03-09 2013-03-08 Particules d'oxyde à base de terres rares et utilisation notamment en imagerie
US14/383,859 US20150010476A1 (en) 2012-03-09 2013-03-08 Rare Earth Oxide Particles and Use Thereof in Particular Imaging
CN201380023918.1A CN104302731B (zh) 2012-03-09 2013-03-08 稀土氧化物颗粒及其用途、特别是在成像中的用途
US15/877,042 US20180161461A1 (en) 2012-03-09 2018-01-22 Rare Earth Oxide Particles and Use Thereof in Particular In Imaging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1252167A FR2987831A1 (fr) 2012-03-09 2012-03-09 Particules d'oxyde a base de terres rares et utilisation notamment en imagerie

Publications (1)

Publication Number Publication Date
FR2987831A1 true FR2987831A1 (fr) 2013-09-13

Family

ID=48083471

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1252167A Withdrawn FR2987831A1 (fr) 2012-03-09 2012-03-09 Particules d'oxyde a base de terres rares et utilisation notamment en imagerie

Country Status (6)

Country Link
US (2) US20150010476A1 (enExample)
EP (1) EP2823016A1 (enExample)
JP (1) JP6318096B2 (enExample)
CN (1) CN104302731B (enExample)
FR (1) FR2987831A1 (enExample)
WO (1) WO2013132197A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2531336B (en) * 2014-10-17 2019-04-10 Thermo Fisher Scient Bremen Gmbh Method and apparatus for the analysis of molecules using mass spectrometry and optical spectroscopy
FR3069927B1 (fr) * 2017-08-04 2021-06-04 Ecole Polytech Procede de detection ultra-sensible a l'aide de particules photoluminescentes
US11357085B2 (en) * 2017-09-25 2022-06-07 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Adaptive solid-state luminescent phosphors
US11279656B2 (en) 2017-10-27 2022-03-22 Applied Materials, Inc. Nanopowders, nanoceramic materials and methods of making and use thereof
CN114381255B (zh) * 2021-10-25 2022-10-11 中国科学院福建物质结构研究所 一种放射性医用同位素标记的稀土掺杂纳米材料和pet显像诊疗剂及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1473347A1 (en) * 2003-04-30 2004-11-03 Nanosolutions GmbH Core/shell nanoparticles suitable for (F) RET-assays
CN101368098B (zh) * 2008-07-29 2011-07-13 浙江理工大学 YVO4:Eu3+/YPO4核壳结构纳米荧光粉及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2283674T3 (es) * 2003-04-30 2007-11-01 Centrum Fur Angewandte Nanotechnologie (Can) Gmbh Nanoparticulas de cucleos/recubrimientos luminiscentes.
DE102009012698A1 (de) * 2009-03-11 2010-09-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Partikel mit einer lumineszierenden anorganischen Schale, Verfahren zur Beschichtung von Partikeln sowie deren Verwendung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1473347A1 (en) * 2003-04-30 2004-11-03 Nanosolutions GmbH Core/shell nanoparticles suitable for (F) RET-assays
CN101368098B (zh) * 2008-07-29 2011-07-13 浙江理工大学 YVO4:Eu3+/YPO4核壳结构纳米荧光粉及其制备方法

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BUISSETTE V ET AL: "LUMINESCENT CORE/SHELL NANOPARTICLES WITH A RHABDOPHANE LNPO4-XH2O STRUCTURE: STABILIZATION OF CE3+-DOPED COMPOSITIONS", ADVANCED FUNCTIONAL MATERIALS, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, vol. 16, no. 3, 3 February 2006 (2006-02-03), pages 351 - 355, XP001238611, ISSN: 1616-301X, DOI: 10.1002/ADFM.200500285 *
HONGLIANG ZHU ET AL: "Highly Enhanced Photoluminescence from YVO 4 :Eu 3+ @YPO 4 Core/Shell Heteronanostructures", JOURNAL OF PHYSICAL CHEMISTRY C, vol. 113, no. 24, 18 June 2009 (2009-06-18), pages 10402 - 10406, XP055041342, ISSN: 1932-7447, DOI: 10.1021/jp900242j *
HONGLIANG ZHU ET AL: "Synthesis of YVO4:Eu3+/YBO3 Heteronanostructures with Enhanced Photoluminescence Properties", NANOSCALE RESEARCH LETTERS, vol. 4, no. 9, 1 September 2009 (2009-09-01), pages 1009 - 1014, XP055041327, ISSN: 1931-7573, DOI: 10.1007/s11671-009-9349-z *
JIA-CAI ZHOU ET AL: "Fluorescent-magnetic nanocrystals: synthesis and property of YPxV1-xO4:Eu@GdPO4 core/shell structure", NANOSCALE, vol. 3, no. 5, 1 January 2011 (2011-01-01), pages 1977, XP055041305, ISSN: 2040-3364, DOI: 10.1039/c0nr01006e *
MENGLEI CHANG ET AL: "Fabrication of novel luminor Y2O3:Eu3+SIGMAiO2@YVO4:Eu3+ with core/shell heteronanostructure", NANOTECHNOLOGY, IOP, BRISTOL, GB, vol. 19, no. 7, 20 February 2008 (2008-02-20), pages 75711, XP020129839, ISSN: 0957-4484 *
NINGTHOUJAM R S ET AL: "Energy transfer process and optimum emission studies in luminescence of core-shell nanoparticles: YVO4:Eu-YVO4 and surface state analysis", JOURNAL OF ALLOYS AND COMPOUNDS, ELSEVIER SEQUOIA, LAUSANNE, CH, vol. 484, no. 1-2, 18 September 2009 (2009-09-18), pages 782 - 789, XP026586532, ISSN: 0925-8388, [retrieved on 20090518], DOI: 10.1016/J.JALLCOM.2009.05.044 *
SINGH L ET AL: "Critical view on energy transfer, site symmetry, improvement in luminescence of Eu3+ , Dy3+ doped YVO4 by core-shell formation", JOURNAL OF APPLIED PHYSICS, AMERICAN INSTITUTE OF PHYSICS. NEW YORK, US, vol. 107, no. 10, 20 May 2010 (2010-05-20), pages 104304 - 104304, XP012132730, ISSN: 0021-8979, DOI: 10.1063/1.3373409 *
SINGH N ET AL: "Luminescence study of Eu3+ doped GdVO4 nanoparticles: Concentration, particle size, and core/shell effects", JOURNAL OF APPLIED PHYSICS, AMERICAN INSTITUTE OF PHYSICS. NEW YORK, US, vol. 104, no. 10, 19 November 2008 (2008-11-19), pages 104307 - 104307, XP012116544, ISSN: 0021-8979, DOI: 10.1063/1.3026612 *

Also Published As

Publication number Publication date
EP2823016A1 (fr) 2015-01-14
US20180161461A1 (en) 2018-06-14
WO2013132197A1 (fr) 2013-09-12
JP6318096B2 (ja) 2018-04-25
JP2015514689A (ja) 2015-05-21
CN104302731B (zh) 2016-09-14
US20150010476A1 (en) 2015-01-08
CN104302731A (zh) 2015-01-21

Similar Documents

Publication Publication Date Title
Marasini et al. Integration of gadolinium in nanostructure for contrast enhanced‐magnetic resonance imaging
Zhou et al. Upconversion nanophosphors for small-animal imaging
Xu et al. Nanoliposomes co-encapsulating CT imaging contrast agent and photosensitizer for enhanced, imaging guided photodynamic therapy of cancer
EP2200659B1 (fr) Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants
Huang et al. Multimodality and nanoparticles in medical imaging
Harrison et al. Multimeric near IR–MR contrast agent for multimodal in vivo imaging
Zhou et al. Bio-modified Fe 3 O 4 core/Au shell nanoparticles for targeting and multimodal imaging of cancer cells
KR101043407B1 (ko) 암 표적성이 우수한 단백질 복합체 및 이의 제조방법
US10973933B2 (en) Nanoparticles for diagnosis and treatment of tumors
Henderson et al. Routes to potentially safer t 1 magnetic resonance imaging contrast in a compact plasmonic nanoparticle with enhanced fluorescence
Douma et al. Nanoparticles for optical molecular imaging of atherosclerosis
Jinlei et al. Simultaneous realization of persistent luminescence and CT dual-mode imaging by x-ray recharged Bi2Ga4O9: Cr nanoprobes in depth-independent tumors
Akhtar et al. Radiolabeled human protein-functionalized upconversion nanoparticles for multimodal cancer imaging
Cheng et al. Near infrared receptor-targeted nanoprobes for early diagnosis of cancers
US20180161461A1 (en) Rare Earth Oxide Particles and Use Thereof in Particular In Imaging
Kitture et al. Hybrid nanostructures for in vivo imaging
Pudakalakatti et al. Hyperpolarized MRI with silicon micro and nanoparticles: Principles and applications
Song et al. A multifunctional nanoprobe based on europium (iii) complex–Fe 3 O 4 nanoparticles for bimodal time-gated luminescence/magnetic resonance imaging of cancer cells in vitro and in vivo
KR100825939B1 (ko) 근적외선 형광체가 결합된 양친성 고분자의 나노 입자를포함하는 암 진단용 조영제
Hollis et al. Hybrid nanocrystal as a versatile platform for cancer theranostics
FR3099883A1 (fr) Nanoparticules pour le traitement du cancer par rayonnement de radiofréquence
Tessitore et al. Lanthanide-doped nanoparticles in biological imaging and bioassays
Bulmahn Nanochemistry for Nanomedicine: Design, Synthesis, and Applications
Riya et al. Applications of Nanoparticles in Bioimaging
FR2930890A1 (fr) Nouveaux agents de radiotherapie ciblee ou de curietherapie a base d'oxydes ou d'oxo-hydroxydes de terre rare

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20201109